Noria SF, Shelby RD, Atkins KD, et al
Potential heart health benefits Early research indicates that GLP-1 medications may: Reduce the risk of major cardiovascular events, such as heart attack and stroke, in people with heart disease and diabetes
The safety and effectiveness of taking L-Carnitine / Levocarnitine daily depend on the individual's health condition and the purpose for which it is being taken
The phenomenon has developed a viral name to describe the gaunt, hollowed appearance some patients develop after rapid medication-driven weight loss
Wider than that, though, is a vexed question that has haunted the corridors of sports global anti-doping apparatus for more than two years now: Should semaglutide the active ingredient in Ozempic, Wegovy, and the broader family of GLP-1 receptor agonist medications be added to the World Anti-Doping Agencys Prohibited List